ESR1 and breast carcinoma: More importantly, Z-LIG remarkably promoted the enrichment of Ace-H3 (lys9/14) in the ERα promoter region, suggesting histone modification may contribute to Z-LIG mediated ERα re-expression in ERα− breast cancer cells.